Items Tagged with 'Perrigo'


Perrigo acquires US rights to drug line for $380M

November 23, 2015
Over-the-counter and prescription drug maker Perrigo is acquiring the U.S. rights to an AstraZeneca drug line for Crohn’s disease for $380 million. Read More

Perrigo shareholders reject hostile takeover bid

November 13, 2015
A rival drug maker has failed in its hostile takeover bid for over-the-counter and prescription medicine maker Perrigo. Read More

Partners launch 'Perrigo Pride' campaign

November 10, 2015
A group of economic development organizations are supporting Perrigo, which is the target of a hostile takeover bid, with a "pride"-themed marketing campaign. Read More

Perrigo plans 800 layoffs and $2B share buyback

October 22, 2015
Perrigo has announced that it will lay off about 800 employees globally as part of a restructuring plan, as well as a $2-billion share repurchase plan. Read More

Perrigo advises shareholders to reject hostile takeover bid

September 17, 2015
Perrigo has advised shareholders to reject a hostile takeover bid by a rival drug maker. Read More

Drug company makes hostile takeover bid for Perrigo

September 15, 2015
A rival drug maker that has repeatedly attempted to acquire Perrigo is going directly to Perrigo’s shareholders with an offer. Read More

Drug maker acquires German brand

July 24, 2015
An over-the-counter drug maker is acquiring a German dietary supplement brand to build its portfolio and market share in Europe. Read More

Drug maker acquires European brands

June 3, 2015
An over-the-counter drug maker will add several European brands to its portfolio following a recent acquisition agreement. Read More

Perrigo buys Mexico pharma operation for $34M

May 13, 2015
| By AP
Perrigo has bought the Mexico operations of Pantheon Pharmaceuticals, expanding its business in that country and giving it the ability to make drugs in soft gel form. Read More

Perrigo rejects latest acquisition offer

April 29, 2015
A rival drug maker has upped its bid for over-the-counter medicine maker Perrigo, but Perrigo continues to refuse the company’s unsolicited offers. Read More